The facility, which is expected to be operational in the fourth quarter of next financial year, will have facilities such as process chemistry labs, oncology chemical labs, formulation R&D labs, process engineering labs, hydrogenation labs.
In addition, it will have stability chambers, kilo labs, API pilot plant with clean air systems, pilot plant for formulations and library catering to API and formulations.
The facility, which is being established with an investment of $872,578 will have a capacity to house more than 300 scientists.
MSN Laboratories executive director Bharat Reddy said the lab will be an integrated technology development centre to work on both APIs and formulations.